Please use this identifier to cite or link to this item:
http://hdl.handle.net/10553/135667
| Title: | Fucoidan - A valuable source from the ocean to pharmaceutical |
| Authors: | Pacheco, D. García Poza, Sara Cotas, J. Gonçalves, A. M. M. Pereira, L. |
| UNESCO Clasification: | 251092 Acuicultura marina 230290 Bioquímica de alimentos 2390 Química farmacéutica |
| Keywords: | Seaweed Biodiversity Biomolecule Bioactive compound Pharmaceutical applications |
| Issue Date: | 2020 |
| Project: | UIDB/04292/2020 – MARE - Marine and Environmental Sciences Centre UID/AMB/50017/2019 - CESAM - Centre for Environmental and Marine Studies MENU - Marine Macroalgae: Alternative recipes for a daily nutritional diet (FA_05_2017_011) |
| Journal: | Frontiers in drug, chemistry and clinical research |
| Abstract: | Fucoidan is one of the most relevant polysaccharides synthesized by Phaeophyceae class (brown seaweeds). Previous research reveals widespread fucoidan bioactivity properties, like antitumoral, anti-inflammatory, antithrombotic or immunomodulatory. Fucoidan extraction and purification methods are the current challenge, in order to obtain this biomolecule that presents different conformations within several seaweed species. The main goal of this mini review is to give an overview of fucoidan pharmaceutical applications research and to support the potential of this biomolecule to be explored by science and industry. |
| URI: | http://hdl.handle.net/10553/135667 |
| ISSN: | 2631-5424 |
| DOI: | 10.15761/FDCCR.1000141 |
| Source: | Frontiers in Drug Chemistry and Clinical Reserarch [ISSN 2631-5424], v. 3, n. 1, (Enero 2020) |
| Appears in Collections: | Reviews |
Items in accedaCRIS are protected by copyright, with all rights reserved, unless otherwise indicated.